INTRODUCTION
============

Over the past two decades, multidrug-resistant *Acinetobacter baumannii* has been globally recognized as an important cause of nosocomial infections \[[@B1]\]. Both uncanny environmental adaptation and rapid acquisition of resistant genes contribute to the ability of *A. baumannii* to be such a successful pathogen \[[@B2]\]. The spread of these resistant genes is mainly through horizontal transfer of plasmids, transposons, or integrons that carry clusters of genes resistant to several antibiotic families \[[@B3]\]. Of these antibiotic-resistance mechanisms, integrons are considered unique for their capacity to cluster and express resistance genes \[[@B4]\]. At present, five classes of mobile integrons are known to have a role in the dissemination of antibiotic-resistance genes. Class 1 integrons are most commonly found in the clinical isolates of gram-negative bacteria and more than hundred accessory genes are known to confer resistance. By contrast, only six different resistance cassettes have been found that are associated with class 2 integrons \[[@B5]\]. Previous studies showed that class 1 integrons and the pool of associated gene cassettes are major contributors to the multidrug resistance of *A. baumannii* \[[@B6], [@B7]\]. As a result, integrons are regarded as a useful marker for the epidemiological study of *A. baumannii* \[[@B8]\].

The aims of this study were to understand the molecular epidemiology of integron-associated gene cassettes in *A. baumannii* among the four hospitals in northern Taiwan and to clarify the relationship between the presence of integrons and antibiotic-resistant phenotypes.

METHODS
=======

1. Specimen collection and strain identification
------------------------------------------------

This study was conducted in Tao-Yuan, Hsin-Chu, Chut-Tung, and Miao-Li General Hospitals, Department of Health (DOH), Executive Yuan, Taiwan between June and December in 2009. Ten imipenem-resistant and ten imipenem-susceptible *Acinetobacter* species were consecutively collected in these four regional hospitals. Each isolate was sampled from different patients. Organisms were classified as belonging to the genus *Acinetobacter* by using the Vitek system (Biomerieux Vitek, Inc., Hazelwood, MO, USA). Identification of these isolates as *A. baumannii* was performed by one-tube multiplex PCR, based on the method of Chen et al. \[[@B9]\].

2. Antimicrobial susceptibility test
------------------------------------

Susceptibilities to antimicrobial agents were determined by the disk diffusion method, in accordance with the guidelines of the Clinical and Laboratory Standards Institute \[[@B10]\]. The agents tested included ampicillin/sulbactam, piperacillin/tazobactam, gentamicin, amikacin, ciprofloxacin, levofloxacin, trimethoprim/sulfamethoxazole, ceftazidime, and imipenem.

3. Detection of integrons and their gene cassettes
--------------------------------------------------

Detection of class 1 and 2 integrase genes (*intI1* and *intI2*) and integron gene cassettes was performed by PCR, as described previously \[[@B11]\]. Integron gene cassettes were detected using 5\' CS and 3\' CS primers. The target gene fragments were isolated with the Gel Elution Kit, FavorPrep (Favorgen Biotech Corporation, Ping-Tung, Taiwan), and the yT&A Cloning Kit from Yeastern Biotech Co., Ltd. (Taipei, Taiwan). Confirmation of the gene cassette sizes was performed by restriction fragment length polymorphism (RFLP) with the help of NEBcutter V2.0 (New England Biolab Inc. Ipswich, MA, USA) to verify the enzyme cutting sites \[[@B12]\]. The expected sizes of amplified DNA fragments confirmed the identity of the gene cassettes. The integron gene cassette amplicons were then sequenced and compared to those registered in the National Center for Biotechnology Information (NCBI) database. Amplification fragments that were not of the expected sizes were subjected to further sequencing.

4. DNA fingerprinting of imipenem-resistant *A. baumannii* by rep-PCR
---------------------------------------------------------------------

To clarify the relationship between the genotypes of imipenem-resistant *A. baumannii* and the distribution of integrons with gene cassettes, repetitive-sequence-based PCR (rep-PCR) was performed for DNA fingerprinting as described by Misbah et al. \[[@B13]\]. REP-1 (NNN NCG NCG NCA TCN GGC) and REP-2 (NCG NCT TAT CNG GCC TAC) primers were used for DNA amplification. The PCR conditions for amplification were as follows: initial denaturation at 94℃ for 5 min, followed by 30 cycles of denaturation at 90℃ for 30 sec, primer annealing at 32℃ for 1 min, and primer extension at 65℃ for 8 min. Amplification products were resolved by electrophoresis at 50 V for 2.5 hr on 1.8% agarose gels. After staining with ethidium bromide, each gel was visualized under UV light. The rep-PCR profiles of the *A. baumannii* were analyzed with Numerical Taxonomy and Multivariate Analysis System version 2.0 (Applied Biostatistics Inc., Setauket, NY, USA). Cluster analysis for rep-PCR DNA fingerprints was performed by construction of a dendrogram, which was calculated by using the band-based dice coefficient method. A similarity matrix was generated and subsequently clustered using the unweighted pair group method with arithmetic means.

5. Stastitical analysis
-----------------------

The susceptibility difference between integron-positive and integron-negative *A. baumannii* strains was analyzed by chi-square or Fisher\'s exact test, as appropriate. The differences between two groups of isolates were considered significant at *P*\<0.05. Data entry and analyses were performed using the Statistical Package for the Social Sciences (SPSS) software version 15.0 (SPSS Inc., Chicago, IL, USA).

RESULTS
=======

Eighty non-duplicated *Acinetobacter* species isolates were collected from four regional hospitals in northern Taiwan. Of all the isolates, 65 were identified as *A. baumannii*, according to the presence of an internal 208-bp fragment from the intergenic spacer region, and the remaining 15 isolates as other *Acinetobacter* species. Around 72% of the *A. baumannii* isolates (47/65) carried class 1 integrase genes; however, none of the 65 isolates possessed class 2 integrase genes. The integron-positive strains were significantly more resistant to all of the tested antibiotics compared to the integrase-negative strains ([Table 1](#T1){ref-type="table"}). In the integron-positive group, the resistance ratios of all the tested antimicrobials, except imipenem, were \>89%, while 68% of the isolates were resistant to imipenem.

Integron cassette genes were found in all class 1 integrase-containing isolates. Three different gene cassette array fragments, namely, 2.3 kb, 1.8 kb, and 3.0 kb, were detected. They were identified as *aacA4*-*catB8*-*aadA1* (Genbank accession no. AY557339), *dhfrXII*-*orfF*-*aadA2* (GenBank accession no. DQ141318), and *aacC1*-*orfP*-*orfP*-*orfQ*-*aadA1* (Genbank accession no. AY577724) by RFLP and sequencing. With the proper restriction enzymes, the amplicons of the three gene cassettes can be divided into two corresponding restriction fragment sizes, which are shown in [Table 2](#T2){ref-type="table"}. The integrase-containing isolates can further be categorized into four types according to the combination of gene cassette arrays: type I (91.5%, 43/47) containing the 2.3 kb fragment only, type II containing the 2.3 kb and 3.0 kb fragments (2.1%, 1/47), type III containing the 2.3 kb and 1.8 kb fragments (2.1%, 1/47), and type IV containing the 2.3 kb, 3.0 kb, and 1.8 kb fragments (4.3%, 2/47). [Table 3](#T3){ref-type="table"} shows the antibiotic resistance phenotypes of the four types of *A. baumannii* with different gene cassette arrays. All the four types of *A. baumannii* were multidrug resistant in nature and not susceptible to ampicillin/sulbactam, gentamicin, ciprofloxacin, or levofloxacin. With the exception of type II, 95% of the other types were resistant to amikacin. Despite this, neither the metallo-β-lactamase (MBL) nor the carbapenem-hydrolyzing class D β-lactamase (CHDL) gene-carrying cassettes were found in the integrons. Type I had high ceftazidime (95.3%) and imipenem (67%) resistance rates.

A dendrogram was created to represent the rep-PCR fingerprints of the 38 imipenem-resistant *A. baumannii* strains ([Fig. 1](#F1){ref-type="fig"}). Of these strains, 84% (32/38) constitutes cluster I and 16% (6/38) constitutes cluster II at an 80% similarity cut-off value.

DISCUSSION
==========

Integrase gene PCR has been proposed as a method for the routine screening and identification necessary for the surveillance of clinical isolates of *A. baumannii* with epidemic potential \[[@B14]\]. Previous studies showed that class 1 integrons could be found in 44-84% of *A. baumannii* clinical isolates \[[@B15], [@B16]\]. Even in *Acinetobacter* complex isolates, integron-positive rates can go above 94% \[[@B17]\]. With 72% of the isolates studied in this study carrying integrons and integron-positive strains being more resistant to all of the tested antibiotics, we propose that the presence of integrons can be used as a representative marker of multidrug resistance in *A. baumannii*.

With regard to genotyping for *A. baumannii*, pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and rep-PCR have been used in previous studies \[[@B18]-[@B20]\]. While PFGE is still considered the gold standard for typing the outbreak-related isolates of *A. baumannii* \[[@B18]\], MLST is primarily useful for population genetic studies \[[@B19]\]. Despite inter-laboratory variability of rep-PCR, this method has the advantage of being less labor-intensive than PFGE and MLST. Intra-laboratory clustering of *A. baumannii* has been proved to be well conserved \[[@B20]\] and to correlate well with MLST results \[[@B21]\], demonstrating the robustness of rep-PCR. In this study, one rep-PCR major cluster (84%) was found among the four regional hospitals in northern Taiwan. It seems that the strains of this cluster spread among these hospitals and disseminated the class I integron with their gene cassettes.

Two of the three gene cassette arrays in the present study, namely, *aacA4-catB8-aadA1* and *aacC1-orfP-orfP-orfQ-aadA1*, have been documented in our previous study \[[@B22]\]. The former cassette array, which can be found in *A. baumannii* worldwide \[[@B15], [@B23]\], was the most prevalent (100%) in this study, while the latter was present in only three isolates despite its wide distribution in the strains of the European clones I and II from many countries \[[@B24]\]. Another cassette array *dhfrXII*-*orfF*-*aadA2*, which has been reported in other studies in Taiwan \[[@B25]\], can be found in three isolates. Although there are differences of cassette array types among our study and the previous studies in Taiwan \[[@B25], [@B26]\], a high percentage of *aacA4*-*catB8*-*aadA1* existence in class 1 integrons implicates this cassette as a prevalent one and raises the possibility of the same gene cassette presence among epidemiologically unrelated *A. baumannii* strains.

There was a significant increase in the proportion of the number of health-associated infections caused by carbapenem-resistant *A. baumannii* over that by all strains of *A. baumannii* from 14% in 2003 to 46% in 2008 in Taiwan \[[@B27]\]. We found that imipenem-resistant *A. baumannii* had high integron-carrying rates, although, no MBL or CHDL genes in the integrons were detected in this study. Our previous study disclosed the presence of CHDL in the clinical isolates of *A. baumannii* from northern Taiwan \[[@B28]\]. However, we did not explore the full spectrum of resistance genes in our clinical isolates any further because we chose to focus on the relationship between the antimicrobial resistance pattern and the gene cassette arrays of integrons in this study. The resistance rates to all the tested antibiotics, except imipenem, of the collected *A. baumannii* isolates were \>70%. However, the presence of integrons with related gene cassettes cannot be responsible for all these resistance phenotypes. Only three categories of gene cassettes, including aminoglycoside-resistant (*aaCA4*, *aacC1*, *aadA1*, *aadA2*), chloramphenicol-resistant (*catB8*), and trimethoprim/sulfamethoxazole-resistant (*dhfrXII*), were identified in spite of previous studies reporting integrons carrying carbepenemase genes.

The whole genome pyrosequencing of an epidemic multidrug-resistant *A. baumannii* strain belonging to the European clone II group showed the presence of an island containing seven resistance genes, including a class 1 integron carrying the *aacA4* and the *blaOXA-20* β-lactamase genes \[[@B29]\]. The correlation between the presence of integrons and certain resistance determinants might explain such multidrug resistance manifestation of integron-positive *A. baumannii* strains. Of the 47 integron-carrying *A. baumannii* isolates, three harboring aminoglycoside encoding genes did not confer resistance to amikacin. A similar finding was reported by Huang et al. \[[@B7]\]. Further studies are needed to determine whether mutations are occurring inside the gene cassettes or in the upstream sequence of the cassette in order to affect cassette gene expression.

In conclusion, the present work gave a brief description on the molecular epidemiology of *A. baumannii* integrons and their associated cassette arrays in northern Taiwan. The relationship between antimicrobial resistance and gene cassettes provides insight into the role of integrons in the multidrug resistance of *A. baumannii*.
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###### 

Susceptibility testing results of 65 integron-positive and integron-negative *Acinetobacter baumannii* isolates
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^\*^Resistance included R and I by CLSI; ^†^*P* value of \<0.05 is considered significant in resistance between the integron-positive and integron-negative isolates.

###### 

Restriction enzymes in RFLP and restriction fragments of gene cassette arrays
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^\*^*orfP* (also known as *orfX*, *orfXA*); *orfQ* (also known as *orfX\'*, *orfY*, *orfXB*).

Abbreviation: RFLP, restriction fragment length polymorphism.

###### 

Antibiotic-resistant phenotypes in four types of *Acinetobacter baumannii* with different gene cassette arrays
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Type I: *aacA4-catB8-aadA1*.

Type II: *aacA4-catB8-aadA1* and *aacC1-orfP-orfP-orfQ-aadA1*.

Type III: *aacA4-catB8-aadA1* and *dhfrXII-orfF-aadA2*.

Type IV: *aacA4-catB8-aadA1*, *aacC1-orfP-orfP-orfQ-aadA1* and *dhfrXII-orfF-aadA2*.

^\*^Resistance included R and I by CLSI.
